Flourish Research, backed by private equity firm NMS Capital, announced its acquisition of Valley Clinical Trials, based in the Los Angeles suburb of Northridge, California. The financial terms of the transaction were not disclosed.
Valley Clinical Trials is a leading clinical research site with three locations in California that specialize in cardiology, metabolic and related therapeutic areas. Since its founding in 2010, Valley has rapidly grown into a leading multi-site clinical trials company serving a broad and diverse population of patients in Los Angeles County.
Launched in 2021. Flourish Research is a clinical trial site network. The company has sites throughout Florida, Illinois, North Carolina and Alabama, and Texas. Flourish has conducted more than 3,700 trials across more than 15 therapeutic areas and more than 60 indications.
According to data captured in the LevinPro HC database, this transaction represents the 28th clinical trials acquisition of the year. Additionally, this transaction represents the ninth acquisition completed by Flourish since 2021 and its third in 2023; previously it purchased Matthews, North Carolina-based AMC Research, LLC and Birmingham, Alabama-based Central Research Associates.
